FDA clears Synchron's brain-computer interface device for human trials [Yahoo!]

A company that makes an implantable brain-computer interface (BCI) has been given the go-ahead by the Food and Drug Administration to run a clinical trial with human patients. Synchron plans to start an early feasibility study of its Stentrode implant later this year at Mount Sinai Hospital, New York with six subjects. The company said it will assess the device's "safety and efficacy in patients with severe paralysis."

URL/Links:
FDA clears Synchron's brain-computer interface device for human trials [Yahoo!]